A clinical trial to study the effect of Ranolazine for prevention of atrial fibrillation in patients undergoing coronary artery bypass grafting.
Phase 1
- Conditions
- Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
- Registration Number
- CTRI/2020/03/024206
- Lead Sponsor
- SRM Medical College Hospital And Research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Elective Off pump CABG(OPCAB)
Moderate - Severe LV dysfunction(EF <45%)
Exclusion Criteria
1.Emergency OPCAB
2.Associated Valvular Heart Lesions
3.Redo surgery
4.Renal dysfunction(creatinine >1.8 mg/dl)
5.Hepatic dysfunction(bilirubin >2 mg/dl)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the safety and efficacyTimepoint: 5th post operative day
- Secondary Outcome Measures
Name Time Method To compare the side effectsTimepoint: 6th postoperative day